Under-expressed OGN and EFS, compared to the normal samples, improved survival, reduced tumor recurrence, and reversed the epithelial to mesenchymal transition by inhibiting EGFR/AKT/Zeb-1 in tumors [38,39]. The gene discussed is OGN; the disease is neoplasm.